Sara G. Miller
Sara G. Miller is the health editor for NBC News, Health & Medical Unit.
Sara G. Miller is the health editor for NBC News, Health & Medical Unit.
Latest from Sara G. Miller
FDA rejects first needle-free alternative to EpiPens, calling for more research
The nasal-spray Neffy was rejected by the FDA. The epinephrine nasal spray would've been the first needle-free alternative to EpiPens, but the FDA said additional research was needed.
All signs point to a rise in Covid
Covid cases, hospitalizations, and even deaths, are rising as fall approaches. What to know about the latest cases and variants.
What to know about XBB.1.16, the 'Arcturus' variant
A new Covid variant is spreading in the U.S. The XBB.1.16 variant or Arcturus variant has been linked to the symptom of pink eye.
Omicron symptoms: What science tells us about the illness caused by new subvariants
What are omicron symptoms: Omicron subvariants may have different symptoms than previous Covid strains. What to look out for.
New immune therapy for advanced melanoma offers hope for hard-to-treat disease
An experimental treatment for advanced melanoma is poised to be the next major advance in cancer treatment, top experts say.
Coronavirus in the U.S.: Map of how many cases have been confirmed across the country, by state
U.S. health officials are monitoring for cases in the United States.
'Part of a new normal': Covid reinfections are here to stay
How many times can I get Covid? Are Covid reinfections worse? What is the reinfection rate for the new Covid variant?
Two omicron subvariants gain a bigger foothold in the U.S.
The omicron subvariants BA.4 and BA.5. continue to gain ground in the United States.
Two omicron subvariants gain a bigger foothold in the U.S.
The omicron subvariants BA.4 and BA.5. continue to gain ground in the United States. Are BA.4 and BA.5 subvariants more transmissible?
3 doses of Covid vaccine are effective for kids under 5, Pfizer says
Does Covid vaccine give immunity to kids under 5? A third dose of Pfizer's vaccine for the youngest kids was effective against omicron, Pfizer said.
Pfizer says booster in children 5-11 raises antibodies against omicron
Can 5 year olds get Covid vaccine: A booster dose of the Pfizer-BioNTech Covid vaccine for children ages 5 through 11 raised antibody levels, Pfizer said.
